These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3906676)
21. [Clinical evaluation of cefotetan in pediatrics]. Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N Jpn J Antibiot; 1983 Jun; 36(6):1185-90. PubMed ID: 6581324 [TBL] [Abstract][Full Text] [Related]
22. [Experience with rational cefotetan therapy in in situ and associated surgical infections]. Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980 [No Abstract] [Full Text] [Related]
23. Antimicrobial sensitivity patterns as a guide to the domiciliary treatment of urinary tract infections. Harvey KJ; Smith DD Med J Aust; 1972 Jan; 1(4):177-8. PubMed ID: 4551815 [No Abstract] [Full Text] [Related]
24. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Stein GE Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258 [TBL] [Abstract][Full Text] [Related]
25. Comparison of single dose netilmicin with a five-day course of co-trimoxazole for uncomplicated urinary tract infections. Bailey RR; Blake E; Peddie BA N Z Med J; 1984 Apr; 97(754):262-4. PubMed ID: 6374533 [TBL] [Abstract][Full Text] [Related]
26. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children. Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630 [TBL] [Abstract][Full Text] [Related]
28. Urinary tract infection in women over the age of 65: is age alone a marker of complication? Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732 [TBL] [Abstract][Full Text] [Related]
29. Cefotetan disodium (Cefotan). Med Lett Drugs Ther; 1986 Jul; 28(718):70-2. PubMed ID: 3523182 [No Abstract] [Full Text] [Related]
30. [Effective treatment of urinary tract infection with carbenicillin]. Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081 [No Abstract] [Full Text] [Related]
31. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection. Gelfand MS; Simmons BP; Craft RB; Grogan J; Amarshi N Am J Med; 1993 Mar; 94(3A):126S-130S. PubMed ID: 8452168 [TBL] [Abstract][Full Text] [Related]
32. Comparison of single-dose cefotetan and multidose cefoxitin as intravenous prophylaxis in elective, open biliary tract surgery: a multicentre, double-blind, randomized study. Lapointe RW; Roy AF; Turgeon PL; Lewis RT; Dagenais MH; Joly JR; Scudamore CH; Roy PD; Conly JM; Syrotuik J Can J Surg; 1994 Aug; 37(4):313-8. PubMed ID: 8055389 [TBL] [Abstract][Full Text] [Related]
33. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085 [TBL] [Abstract][Full Text] [Related]
34. Single dose of ofloxacin treatment in women with dysuria and frequency. Simşek F; Dillioğlugil O; Ilker Y; Akdaş A Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825 [TBL] [Abstract][Full Text] [Related]
35. [The use of cefotetan for the prevention of infectious postoperative complications in gynecology]. Doganov N; Dimitrov R; Marinov B; Shtereva K; Nachev A; Bozhilov D; Blagoeva V Akush Ginekol (Sofiia); 1997; 36(1):11-3. PubMed ID: 9289950 [TBL] [Abstract][Full Text] [Related]
36. [The French experience with moxalactam in pneumology]. Leng B; Imbert Y; Coomans D Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790 [TBL] [Abstract][Full Text] [Related]
37. CMY-2 beta-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium. Wu TL; Chia JH; Su LH; Chiu CH; Kuo AJ; Ma L; Siu LK Int J Antimicrob Agents; 2007 Apr; 29(4):410-6. PubMed ID: 17300921 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity and clinical evaluation of cefixime in urinary tract infection. Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D J Med Assoc Thai; 1998 Apr; 81(4):301-4. PubMed ID: 9623027 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087 [TBL] [Abstract][Full Text] [Related]
40. [The treatment of urinary tract infections with sulfafurazole; a single dose or a 7-day course?]. Hirschfeld H; Rietra PJ; Meijman FJ Ned Tijdschr Geneeskd; 1984 Sep; 128(39):1839-42. PubMed ID: 6493377 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]